Biotech Co. Voids Rival's Bioreactor Patent At EPO
A biotechnology company's amended patent over a bioreactor control system is invalid because it introduced features missing from the original blueprint, an appeals panel held in a ruling released Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article